Overcharging liability under DPCO revised under The Drugs Prices Control Order, 2013

The Department of Pharmaceuticals has clarified the framework governing overcharging liability under the Drugs (Prices Control) Order, 2013. Manufacturers demonstrating compliance with prescribed price communication requirements will have their liability restricted to the quantity of stock actually overcharged by distributors or retailers, providing greater regulatory certainty.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.